CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop

Table 1 The relationships between circRNF10 expression and clinical characteristics in patients with BC

Clinical characteristics	Total	circRNF10 expression		P value
Clinical characteristics	Total	High (N = 54)	Low (N = 54)	P value
Age at diagnosis
< 60	35	14	21	0.15
≥ 60	73	40	33	0.15
Molecular subtype
Luminal A	30	14	16	0.420
Luminal B	40	17	23
HER2-positive	14	8	6
TNBC	24	15	9
Stage
I and II	94	51	43	0.022^*
III and IV	14	3	11	0.022^*
Lymph node status
Negative	81	45	36	0.046^*
Positive	27	9	18	0.046^*
Recurrence or distant metastasis
No	93	51	42	0.012^*
Yes	15	3	12	0.012^*

ISSN: 1689-1392